Owc Pharmaceutical Research Corp · OTC:OWCP
Owc Pharmaceutical Research — Sponser Investors' Conference 2015
14 slides from Owc Pharmaceutical Research's conference presentation, Feb 10, 2015
Slide 1: One World Cannabis Ltd. – Investors' Conference
ebOWC oneworldcannabis OWCP pharmaceutical research Ziv Turner, CEO One World Cannabis Ltd. "Sponser” Investors’ conference 10/2/15 ‘©2015 One World Cannabis Ltd ~a wholly owned subsidiary of OWC|
Slide 2: Safe Harbor for Forward-Looking Statements
gbOWC Safe Harbor for Forward- — Looking Statements: Safe Harbor for Forward-Looking Statements: Any statements made in this press release relating to future financial or business performance, conditions, plans, prospects, trends, or strategies and other financial and business matters are forward-lo
Slide 3: One World Cannabis Ltd.
ab OWC OWCP pharmaceutical research ‘oneworldcannabis One World Cannabis Ltd. Established in 2014 by a group of entrepreneurs with extensive knowledge each in his own field. Focused on Research & Development (R&D) of devices and cannabis based treatments that will target variety of diseases and medi
Slide 4: Our Vision
OW ‘oneworldcannabis Our Vision Improving patients’ quality of life worldwide through research and development of new solutions, products and devices derived from Cannabis
Slide 5: What is Medical Cannabis?
gb>OWC What is Medical ‘oneworldcannabis . Cannabis? Tetrahydrocannabinol (THC) Cannabidiol (CBD) + Main Psychoactive molecule in + Medical uses for pain relief and anti- Cannabis infection treatments * 1964 - purely isolated for the first time in Israel by Prof. Raphael Meshulam and others at the H
Slide 6: Goals: R&D
ebOWwec Goals: R&D Leading in R&D for creating new devices and cannabis based treatments to target variety of diseases and medical conditions, by identifying unique and efficient delivery systems: * Medical research and clinical trials will be conducted under Helsinki protocols and other known accep
Slide 7: Goals: Regulatory Consulting
gbOWC Goals: Regulatory — Consulting * OWC is looking to provide consulting services to governments, policy makers and business groups worldwide on matters promoting regulations and treatments of Medical Cannabis + These services are based on knowledge and experience gained through the Israeli modul
Slide 8: The US Market
gbOWC The US Market ‘oneworldcannabis * Today: Lack of scientific proven knowledge and the absence of quality assurance of medical cannabis products * 23 states and District of Colombia with active regulations for medical cannabis; 5 states with full legalization + More states with tenders to implem
Slide 9: 2020: The Future of Medical Cannabis
ebOWwc 2020: The Future of Medical Cannabis in 5 Years + Establishing a scientific base for proving the efficiency and quality stability of medical grade cannabis products * International acceptance of the legitimacy of treatment using medical cannabis products * Standardization of independant proto
Slide 10: 2025: The Future of Medical Cannabis
abOwc 2025: The Future of Medical Cannabis in 10 Years + Active research for full FDA medicine approval * Deeper research for uncharted cannabinoids * Creating specific cannabis breeds targeting medical illnesses and conditions * Developing mass farming production of Hemp for industrial uses such as
Slide 11: The A Team
OW ‘oneworldcannabis The A Team OWC was founded by a team of experts each in his own field of expertise in medical cannabis , research, health care management, interna‘ | me Dr. Yehuda Baruch Research institute Operating Director. CEO of Abarbanel Mental Health Center in Bat Yam, was the head of the
Slide 12: OWC Markets Penetration
qi OWC Markets Penetration ‘oneworidcannabis Costs * OWC’s research budget for 2015: 400K$ + Full patents: ~100K$ per patent * M&S costs: 100K$ per product licensing Q3\2016 a2i2016 4 r Migraine aai2015 4 study First unique its 2212015 4 Pe iininan a iminary dy te 3 ae mene Preliminary © peoriasis a
Slide 13: Feb 2015 Status
qbeOWwC Feb 2015 Status: ‘oneworidcannabis R&D: * Two signed contracts with Sheba and Soroka hospitals to perform clinical trails + Negotiations with additional hospitals for other studies * First Helsinki protocol accepted for Myeloma study + Application for 6 additional Provisional studies * 4more
Slide 14: Contact details
Contact details: Ziv Turner, CEO One World Cannabis Ltd 22 Shaham st, Petach Tikvah 03-7582657 OWCP pharmaceutical research qPOWC ‘©2015 One World Cannabis Ld -a wholly owned subsidiary of OWC Pharmaceutical Research Corp (OTC OWCP) Delaware corporation.
OWC Pharmaceutical Research — Sponser Investors' Conference 2015 on 6ix